Sam Adams

Sam Adams has a strong background in business operations, finance, and marketing. They have held various roles in different companies, starting with their current position as Co-Founder and Head of Business Operations at Fenster Analytics since 2022. Prior to this, Sam was the Director of Finance and Business Operations at Endsulin, a gene therapy company focused on treating Type 1 diabetes. They also worked as the Channel Development Leader at Cardiac Science, where they successfully established new distribution channels before the company was acquired by ZOLL Medical. Sam also served as the Head of Business Development at Wisconsin Center for Education Products and Services, where they achieved significant revenue growth. They gained experience as the General Manager at Stealth Therapeutics, leading operations and fundraising efforts before a strategic exit. Additionally, Sam served as the Chief Executive Officer at Echometrix, commercializing quantitative ultrasound technology. They started their career at GE Healthcare as a Senior Marketing Manager, with a focus on medical technology and life sciences.

Sam Adams has a diverse education history spanning over several years. In 1994, they began their undergraduate studies at Colorado College, where they pursued a Bachelor of Arts degree in International Political Economy. Sam successfully completed their degree in 1998.

During their undergraduate years in 1997, Sam briefly attended Beloit College for a semester in Quito, Ecuador to enrich their educational experience. Although they did not pursue a specific degree at Beloit College, they focused their studies on the field of study.

Following their undergraduate studies, Sam Adams went on to pursue a Master's in Business Administration (MBA) at the University of Wisconsin-Madison. Sam specialized in Entrepreneurship and Marketing and attended the university from 2002 to 2004.